Pharmaceutical manufacturing, research, and services focused on global healthcare in India.
Annual revenue $30,396 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Mabel Pharmaceuticals

Mabel Pharmaceuticals is a company. Mabel Pharmaceuticals offers products and services including Pharmaceutical Products and Research and Innovation Services.

Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $30.4 K (USD)
    42.97
    as on Mar 31, 2022
  • Net Profit
    $268.28 (USD)
    -2.02
    as on Mar 31, 2022
  • EBITDA
    -$9.54 K (USD)
    -91.84
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Mabel Pharmaceuticals

Mabel Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Research and Innovation Services.

Product name locked
Category locked
Primary

Pharmaceutical products are manufactured and supplied to meet global healthcare needs with an emphasis on innovation and quality.

Product name locked
Category locked
Locked

Research and innovation services are provided to support competitive advantages in the pharmaceutical sector.

Funding Insights of Mabel Pharmaceuticals

Premium access

Detailed funding history for Mabel Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Mabel Pharmaceuticals

Investments
Premium access

Investment portfolio details for Mabel Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Mabel Pharmaceuticals

Premium access

Detailed financials for Mabel Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Mabel Pharmaceuticals Comparisons

Mabel Pharmaceuticals Primary company
Description
Pharmaceutical manufacturing, research, and services focused...
Location
-
Founded Year
-
Annual Revenue
$30.4 K (USD)
Net Profit
$268.28 (USD)
EBITDA
-$9.54 K (USD)
Employees
Not available
Premium access

Peer comparison for Mabel Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Mabel Pharmaceuticals

Premium access

Detailed competitors of Mabel Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Mabel Pharmaceuticals

Premium access

Complete news archive for Mabel Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mabel Pharmaceuticals

Annual revenue of Mabel Pharmaceuticals is $30.4K as on Mar 31, 2022.

Mabel Pharmaceuticals is recognized as a client-centric organization where ethical business policies are observed to foster reliability and trust. Quality assurance systems are established to implement preventive measures and train workforces effectively, ensuring objectives are met. A focused approach is adopted to serve global healthcare needs through empathy, innovation, and technology, with an understanding of customer requirements driving the use of cutting-edge solutions. Research and development are emphasized as key strategies for achieving competitive advantages, while commitments to excellence and customer satisfaction are upheld through extensive experience and documentation of essential steps.

Mabel Pharmaceuticals offers Pharmaceutical Products and Research and Innovation Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available